Skip to main content
Premium Trial:

Request an Annual Quote

Van Andel Institute, Spectrum Health Create Lab to Study Genomics, Proteomics of Disease

NEW YORK (GenomeWeb News) – The Van Andel Institute and Spectrum Health have started a molecular technologies lab that will study genomics and proteomics for application in cancer, heart disease, mental illness, and other diseases, Spectrum Health said today.
 
Spectrum, a non-profit group that operates seven hospitals in Western Michigan, said the Center for Molecular Medicine, located in Grand Rapids, has $6 million in funding.
 
The CMM will use Van Andel’s infrastructure and employees along with Spectrum’s clinical lab and research resources.
 
Van Andel CEO and Chairman David Van Andel said Spectrum has “a large patient population which allows us to apply what we're learning directly into the clinical setting."
 
The CMM will house and use DNA and RNA extraction, DNA microarrays, multiplex protein detection, and gene-expression profiling.
 
Directing the CMM will be Dan Farkas, who Spectrum said has established three other hospital-based molecular diagnostics labs.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.